Specialty-pharmacy and PBM real-world data

Name: Specialty-pharmacy and PBM real-world data: member-level prescription fill histories across commercial, Medicare Part D and Medicaid populations managed by Prime and its government/Medicaid arms, with persistence, adherence (proportion-of-days-covered style), switching and discontinuation sequences for specialty therapies — the published cohort in the source is a GLP-1 persistence/adherence analysis on 4,066 members
Creator: Primetherapeutics

PRIMETHERAPEUTICSManage supplier listing

Specialty-pharmacy and PBM real-world data: member-level prescription fill histories across commercial, Medicare Part D and Medicaid populations managed by Prime and its government/Medicaid arms, with persistence, adherence (proportion-of-days-covered style), switching and discontinuation sequences for specialty therapies — the published cohort in the source is a GLP-1 persistence/adherence analysis on 4,066 members

Open buyer room →

Sample

Brickroad customers

Sample this dataset before you buy it.

Your sourcing agent asks Primetherapeutics and files the sample in your catalog — private to you.

Start 7-day trialNothing is charged until the trial ends.

Coverage

Universe, instruments and categories.

Industry: Health Care TechnologyHealth Insurance
Instruments: equities
Categories: AlternativeFundamental
Regions: US
Sample tickers: LLYNVOUNHELVCVSCAHMCKAZNAMGNREGN

Dataset card

Type: not stated
Format: Tabular claims and dispensing records (member ID hash, NDC, fill date, days supply, quantity, payer/plan, channel) aggregated into analytical cohorts; externally released only as aggregate statistics in conference abstracts and journal tables
Volume: Very large: a continuous longitudinal fill history per member across all channels (mail-order specialty, retail network, government programs). Estimate billions of dispensing records over a multi-year window, each with payer, plan, NDC, days-supply and cost fields
Users: ~19-20M pharmacy members (inferred: Prime is the fourth-largest US PBM serving roughly that many members across its health-plan owners; the 4,066-member figure in the source is an analysis cohort, not the population)
History: 10 years
Update frequency: not stated
Growth: Active and expanding its RWE output — GLP-1 analyses presented at AMCP 2024 and published in JMCP, with the release explicitly stating further data will be shared as ongoing analyses continue; multiple AMCP abstracts on GLP-1 adherence, persistence/switching and obesity-CV outcomes sit on the same document library
Launched: 2002 for Prime Therapeutics as a PBM (founded by Blue Cross Blue Shield plans); Magellan Rx Management acquired 2019, which is when the specialty-pharmacy dispensing arm that underpins this RWE program came under Prime ownership
Delivery: not stated
Entity mapping: not stated
Sample: not stated
Point-in-time: not stated
Licence: not stated

supplier index read from their site

Primetherapeutics has not added their own details yet. Not yet on file:

Dataset
Data dictionary
Coverage
Provenance
Rights & data handling